新聞/Reuters/Cingulate Submits New Drug Application To FDA For Lead Adhd Asset CTx-1301Cingulate Submits New Drug Application To FDA For Lead Adhd Asset CTx-1301Refinitiv閱讀少於1分鐘CINGCingulate Inc CING:CINGULATE SUBMITS NEW DRUG APPLICATION TO FDA FOR LEAD ADHD ASSET CTX-1301Reuters美國股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
